Skip to content

Birth Weight-discordance in Twins Pregnancy: a Multicenter Retrospective Study

Occurrence of Liveborn Twins With Birth Weight-discordance and Its Relationship to the Adverse Outcomes: a Multicenter Retrospective Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05674214
Enrollment
13440
Registered
2023-01-06
Start date
2020-09-10
Completion date
2022-11-25
Last updated
2023-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Twin; Pregnancy, Affecting Fetus or Newborn

Keywords

twins, birth weigh-discordant, occurrence, birth outcomes, multi-center study

Brief summary

The rate of twin pregnancies in China has increased by 50 percent over the past decade and now stands at about 3 percent. This is significantly higher than the European and American countries. There are significant differences in birth weight of some newborns, that is, birth weight-discordance in twin pregnancies (BWDT). BWDT was significantly associated with fetal death, preterm birth, neonatal death, and neonatal complications. Existing studies mainly focus on the perinatal outcomes of mothers and infants with BWDT, or are reported from small samples in developed countries. The investigators are aware of the need to further explore the occurrence of birth weight inconsistency and adverse neonatal outcomes in China with a large sample. Through retrospective study design, the investigators will collect clinical data of live twin births at multiple study sites, investigate the incidence of BWDT, and analyze its adverse outcomes.

Detailed description

The investigators adopted a multicenter retrospective case-control study design and enrolled live twin births delivered from 2018 to 2020 in 22 hospitals in 12 provinces in China. Children with congenital and hereditary diseases, such as inherited metabolic diseases, complex congenital heart disease, and digestive tract malformations, were excluded from the study. The investigators collected the following information: (1) General information: maternal age, year of delivery, number of delivery, mode of conception, mode of delivery, chorionic nature, education level, newborn sex; (2) Maternal risk factors associated with intrauterine development: induced abortion ≥2 times, placental disease, uterine tumor, gestational diabetes mellitus, gestational hypertension disease, intrahepatic cholestasis, connective tissue disease, hypothyroidism, and chorionic amnitis; (3) Infant birth outcome: gestational age, birth weight, birth length, birth head circumference, very low birth weight infants, ultra-low birth weight infants, the Apgar score, whether transferred to neonatology department. (4) Information of hospitalization during the neonatal period: Pulmonary surfactant use, duration of oxygen therapy, neonatal complications (i.e., pulmonary hemorrhage, BPD, NEC, PDA, ROP, PVL, IVH, anemia, infection, etc.), feeding status (i.e., duration of milk opening, duration of full feeding, feeding style and feeding materials at full feeding, Time to recovery of birth weight), and discharge outcome (i.e., total hospitalization cost, length of stay, gestational age corrected for discharge, discharge status, discharge physique).

Interventions

None listed

Sponsors

Peking University Third Hospital
CollaboratorOTHER
The Affiliated Hospital of Inner Mongolia Medical University
CollaboratorOTHER
The Third Hospital Of BaoGang Group
CollaboratorUNKNOWN
Lanzhou University Second Hospital
CollaboratorOTHER
Yan'an University Affiliated Hospital
CollaboratorOTHER
Xiamen University Women and Children's Hospital
CollaboratorUNKNOWN
Xinxiang Central Hospital
CollaboratorOTHER
Central Hospital of Xiaogan
CollaboratorOTHER
Guizhou Medical University Affiliated Hospital
CollaboratorUNKNOWN
Sichuan Jinxin Women and Children's Hospital
CollaboratorUNKNOWN
The First Affiliated Hospital of Shaoyang University
CollaboratorUNKNOWN
First Affiliated Hospital of Jinan University
CollaboratorOTHER
First Affiliated Hospital of Shantou University Medical College
CollaboratorOTHER
Second Affiliated Hospital of Shantou University Medical College
CollaboratorOTHER
The Second People's Hospital of GuangDong Province
CollaboratorOTHER
Dongguan People's Hospital
CollaboratorOTHER_GOV
Dongguan Binhai Bay Central Hospital
CollaboratorUNKNOWN
Zhongshan People's Hospital, Guangdong, China
CollaboratorOTHER
Huizhou Municipal Central Hospital
CollaboratorOTHER
Yuebei People's Hospital
CollaboratorOTHER
The Third Affiliated Hospital of Guangzhou Medical University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Days to 28 Days
Healthy volunteers
Yes

Inclusion criteria

live twin births 1\. delivered from 2018 to 2020

Exclusion criteria

1. congenital and hereditary diseases 2. inherited metabolic diseases 3. complex congenital heart disease 4. digestive tract malformations

Design outcomes

Primary

MeasureTime frameDescription
birth outcome1 daygestational age
neonatal complications1 monththe morbidity of pulmonary hemorrhage, BPD, NEC, PDA, ROP, PVL, IVH, anemia, infection, etc

Secondary

MeasureTime frameDescription
discharge outcome3 monthstotal hospitalization cost

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026